1. A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. (August 2015) Authors: Kroll, Robin; Seidman, Larry; Ricciotti, Nancy; Howard, Brandon; Weiss, Herman Journal: European journal of contraception & reproductive health care Issue: Volume 20:Number 4(2015:Aug.) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. (August 2015) Authors: Kroll, Robin; Seidman, Larry; Ricciotti, Nancy; Howard, Brandon; Weiss, Herman Journal: European journal of contraception & reproductive health care Issue: Volume 20:Number 4(2015:Aug.) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause. Issue 4 (April 2020) Authors: Fraser, Graeme L.; Lederman, Samuel; Waldbaum, Arthur; Kroll, Robin; Santoro, Nanette; Lee, Misun; Skillern, Laurence; Ramael, Steven Journal: Menopause Issue: Volume 27:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom. Issue 2 (February 2018) Authors: Kroll, Robin; Archer, David F.; Lin, Yuhua; Sniukiene, Vilma; Liu, James H. Journal: Menopause Issue: Volume 25:Issue 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. (June 2016) Authors: Clayton, Anita H; Althof, Stanley E; Kingsberg, Sheryl; DeRogatis, Leonard R; Kroll, Robin; Goldstein, Irwin; Kaminetsky, Jed; Spana, Carl; Lucas, Johna; Jordan, Robert; Portman, David J Journal: Women's health Issue: Volume 12:Number 3(2016) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial. (June 2016) Authors: Clayton, Anita H; Althof, Stanley E; Kingsberg, Sheryl; DeRogatis, Leonard R; Kroll, Robin; Goldstein, Irwin; Kaminetsky, Jed; Spana, Carl; Lucas, Johna; Jordan, Robert; Portman, David J Journal: Women's health Issue: Volume 12:Number 3(2016) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial. (June 2016) Authors: Clayton, Anita H; Althof, Stanley E; Kingsberg, Sheryl; DeRogatis, Leonard R; Kroll, Robin; Goldstein, Irwin; Kaminetsky, Jed; Spana, Carl; Lucas, Johna; Jordan, Robert; Portman, David J Journal: Women's health Issue: Volume 12:Number 3(2016) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Contraceptive Efficacy and Safety of 52 mg Levonorgestrel-Releasing Intrauterine Systems During Years 6–8 of Use: Data From the Mirena Extension Trial [A13]. (May 2022) Authors: Jensen, Jeffrey T.; Lukkari-Lax, Eeva; Schulze, Andrea; Baisden, Kristie W.; Serrani, Marco; Kroll, Robin Journal: Obstetrics and gynecology Issue: Volume 139(2022)Supplement 1 Page Start: 4S Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Contraceptive Efficacy and Safety of 52 mg LNG-IUS for up to Eight Years: Year 6 Data From the Mirena Extension Trial [OP04-1D]. (May 2020) Authors: Jensen, Jeffrey T.; Kroll, Robin; Lynen, Richard F.; Schulze, Andrea; Lukkari-Lax, Eeva Journal: Obstetrics and gynecology Issue: Volume 135(2020)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA). Issue 12 (December 2020) Authors: Santoro, Nanette; Waldbaum, Arthur; Lederman, Samuel; Kroll, Robin; Fraser, Graeme L.; Lademacher, Christopher; Skillern, Laurence; Young, James; Ramael, Steven Journal: Menopause Issue: Volume 27:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗